baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Evotec SE/ DE0005664809 /

07/08/2024 15:54:21	Chg. -	Volume	Bid15:54:21	Ask19/07/2024	Market Capitalization	Dividend Y.	P/E Ratio
5.20EUR	-	280 Turnover: 1,456	-Bid Size: -	-Ask Size: -	1.09 bill.EUR	-	-

GlobeNewswire 14/05 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease

GlobeNewswire 16/01 HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and ...

GlobeNewswire 11/12/2023 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...

GlobeNewswire 07/11/2023 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

GlobeNewswire 20/10/2021 Curexsys Appoints Christian Eckert as Chief Operating Officer

GlobeNewswire 11/10/2021 Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement

GlobeNewswire 26/04/2021 Proactive news headlines including Chase Mining Corporation, Red River Resources, Aurumin and Kazia ...

GlobeNewswire 20/04/2021 Proactive news headlines including Queensland Pacific Metals, Moho Resources, Kazia Therapeutics and...

GlobeNewswire 01/03/2021 Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Preci...

GlobeNewswire 20/08/2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease

GlobeNewswire 04/06/2020 Toronto Innovation Acceleration Partners Expands its LAB150 Portfolio with a Novel Cancer Therapeut...

GlobeNewswire 12/02/2020 TIAP announces New President and CEO

GlobeNewswire 12/12/2019 Toronto Innovation Acceleration Partners (TIAP) adds novel KRAS oncology project to its LAB150 portf...

GlobeNewswire 11/06/2019 Mental Health is Focus of New High-Potential Anti-Depression Project from MaRS Innovation and the Ce...

GlobeNewswire 07/02/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis

GlobeNewswire 15/02/2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE

GlobeNewswire 08/01/2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi

GlobeNewswire 14/09/2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO

GlobeNewswire 29/11/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...

GlobeNewswire 10/11/2011 Evotec reports nine months results: Upside materialising

GlobeNewswire 03/11/2011 Evotec to Report Third Quarter Results on 10 November 2011

GlobeNewswire 27/10/2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi

GlobeNewswire 20/10/2011 Evotec and APEIRON Biologics start next project on the Cbl-b target

GlobeNewswire 05/10/2011 Evotec announces second multi-target collaboration with UCB

Evotec SE/ DE0005664809 /

If you wish to receive reply to your feedback, please provide your email address.